BDBM50533342 Cebranopadol::GRT-6005::GRT6005

SMILES CN(C)[C@]1(CC[C@@]2(CC1)OCCc1c2[nH]c2ccc(F)cc12)c1ccccc1

InChI Key InChIKey=CSMVOZKEWSOFER-RQNOJGIXSA-N

Data  2 KI  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50533342   

TargetMu-type opioid receptor(Homo sapiens (Human))
Astraea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50533342(Cebranopadol | GRT-6005 | GRT6005)
Affinity DataKi:  0.700nMAssay Description:Displacement of [N-allyl-2,3-3H]naloxone from recombinant human mu opioid receptor expressed in CHOK1 cell membranes after 90 mins by scintillation c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Astraea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50533342(Cebranopadol | GRT-6005 | GRT6005)
Affinity DataKi:  0.900nMAssay Description:Displacement of [leucyl-3H]nociceptin from human nociceptin opioid receptor expressed in HEK293 cell membranes after 90 mins by scintillation countin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNociceptin receptor(Homo sapiens (Human))
Astraea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50533342(Cebranopadol | GRT-6005 | GRT6005)
Affinity DataEC50:  13nMAssay Description:Agonist activity at recombinant human nociceptin opioid receptor expressed in CHOK1 cell membranes after 45 mins by GTPgamma(35)S binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astraea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50533342(Cebranopadol | GRT-6005 | GRT6005)
Affinity DataEC50:  1.20nMAssay Description:Agonist activity at recombinant human mu opioid receptor expressed in CHOK1 cell membranes after 45 mins by GTPgamma(35)S binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed